Peginterferon for the treatment of chronic hepatitis B in the era of nucleos(t)ide analogues.

  title={Peginterferon for the treatment of chronic hepatitis B in the era of nucleos(t)ide analogues.},
  author={E. Buster and S. Schalm and H. Janssen},
  journal={Best practice & research. Clinical gastroenterology},
  volume={22 6},
  • E. Buster, S. Schalm, H. Janssen
  • Published 2008
  • Medicine
  • Best practice & research. Clinical gastroenterology
  • The practising clinician is currently faced with a number of effective treatment options for chronic hepatitis B, including two formulations of interferon (standard IFN and pegylated IFN) and five nucleos(t)ide analogues (lamivudine, adefovir, entecavir, telbivudine and tenofovir). Treatment strategies can be divided into those aiming for sustained response after discontinuation of therapy and those that need to be maintained by prolonged antiviral therapy. Sustained response is particularly… CONTINUE READING
    24 Citations
    Peginterferon Monotherapy versus Peginterferon and Lamivudine Combination Therapy for Chronic Hepatitis B
    • Highly Influenced
    Interferon for Hepatitis B: Which Populations Benefit the Most
    Advances in therapeutics for chronic hepatitis B
    • 11
    Hepatitis B genotypes: Role of testing in clinical practice
    Do we need to determine viral genotype in treating chronic hepatitis B?
    • 41


    Pegylated interferons for chronic hepatitis B.
    • 43
    Lamivudine as initial treatment for chronic hepatitis B in the United States.
    • 1,330
    Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B.
    • 1,198
    • PDF
    Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B.
    • 1,145
    • PDF
    Hepatitis B: reflections on the current approach to antiviral therapy.
    • 166